The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Molecular Targets and Anticancer Potential of Indole-3-Carbinol and Its Derivatives
Open accessAbstract
Indole-3-carbinol (I3C) is produced by members of the family Cruciferae, and particularly members of the genus Brassica (e.g., cabbage, radishes, cauliflower, broccoli, Brussels sprouts, and daikon). Under acidic conditions, 13C is converted to a series of oligomeric products (among which 3,3'-diindolylmethane is a major component) thought to be responsible for its biological effects in vivo. In vitro, 13C has been shown to suppress the proliferation of various tumor cells including breast cancer, prostate cancer, endometrial cancer, colon cancer, and leukemic cells; induce G1/S arrest of the cell cycle, and induce apoptosis. The cell cycle arrest involves downregulation of cyclin D1, cyclin E, cyclin- dependent kinase (CDK)2, CDK4, and CDK6 and upregulation of p15, p21, and p27. Apoptosis by I3C involves downregulation antiapoptotic gene products, including Bcl-2, Bcl-xL, survivin, inhibitor-of-apoptosis protein (IAP), X chromosome-linked IAP (XIAP), and Fas-associated death domain protein-like interleukin-1-beta-converting enzyme inhibitory protein (FLIP); upregulation of proapoptotic protein Bax; release of micochondrial cytochrome C; and activation of caspase-9 and caspase-3. This agent inhibits the activation of various transcription factors including nuclear factor-kappaB, SP1, estrogen receptor, androgen receptor and nuclear factor-E2-related factor 2 (Nrf2). This indole potentiates the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through induction of death receptors and synergises with chemotherapeutic agents through downregulation of P-glycoprotein (P-gp). In vivo, I3C was found to be a potent chemopreventive agent for hormonal-dependent cancers such as breast and cervical cancer. These effects are mediated through its ability to induce apoptosis, inhibit DNA-carcinogen adduct formation, and suppress free-radical production, stimulate 2-hydroxylation of estradiol, inhibit invasion and angiogenesis. Numerous studies have indicated that I3C also has a strong hepatoprotective activity against various carcinogens. Initial clinical trials in women have shown that I3C is a promising agent against breast and cervical cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vegetables, Fruit, and Cancer Prevention
STEINMETZ, K. A., & POTTER, J. D. (1996) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(96)00273-8 · Cited by 2,118
Bjeldanes, L. F., Kim, J. Y., Grose, K. R., Bartholomew, J. C., & Bradfield, C. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9543 · Cited by 588
Bonnesen, C., Eggleston, I. M., & Hayes, J. D. (2001) · PubMed · Cited by 466
Chinni, S. R., Li, Y., Upadhyay, S., Koppolu, P. K., & Sarkar, F. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204365 · Cited by 315
Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice
Bradlow, H. L., Michnovicz, J. J., Telang, N. T., & Osborne, M. P. (1991) · Carcinogenesis · doi:10.1093/carcin/12.9.1571 · Cited by 304
Cover, C. M., Hsieh, S. J., Tran, S. H., Hallden, G., Kim, G. S., Bjeldanes, L. F., & Firestone, G. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3838 · Cited by 282
Placebo-Controlled Trial of Indole-3-Carbinol in the Treatment of CIN
Bell, M. C., Crowley-Nowick, P., Bradlow, H. L., Sepkovic, D. W., Schmidt-Grimminger, D., Howell, P., Mayeaux, E. J., Tucker, A., Turbat-Herrera, E. A., & Mathis, J. M. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5847 · Cited by 262
Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.
Grubbs, C. J., Steele, V. E., Casebolt, T. L., Juliana, M. M., Eto, I., Lm, W., Dragnev, K. H., Kelloff, G. J., & Lubet, R. A. (1995) · PubMed · Cited by 237
Manson, M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.9.1729 · Cited by 228
Chen, I., Safe, S., & Bjeldanes, L. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00060-3 · Cited by 222
Anderton, M. J., Manson, M. M., Verschoyle, R. D., Gescher, A., Lamb, J. H., Farmer, P. B., Steward, W. P., & Williams, M. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0163 · Cited by 219
Kojima, T., Tanaka, T., & Mori, H. (1994) · PubMed · Cited by 191
Plant-derived 3,3′-Diindolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells
Le, H. T., Schaldach, C. M., Firestone, G. L., & Bjeldanes, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300588200 · Cited by 182
Induction of Estradiol Metabolism by Dietary Indole-3-carbinol in Humans
Michnovicz, J. J., & Bradlow, H. L. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.11.947 · Cited by 181
Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells
Nachshon-Kedmi, M., Yannai, S., Haj, A., & Fares, F. A. (2003) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(03)00004-8 · Cited by 168
Altered estrogen metabolism and excretion in humans following consumption of indole‐3‐carbinol
Michnovicz, J. J., & Bradlow, H. L. (1991) · Nutrition and Cancer · doi:10.1080/01635589109514141 · Cited by 156
Chang, X. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi018 · Cited by 151
Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells.
Chinni, S. R., & Sarkar, F. H. (2002) · PubMed · Cited by 150
Morse, M. A., LaGreca, S. D., Amin, S., & Chung, F. (1990) · PubMed · Cited by 146
Changes in Levels of Urinary Estrogen Metabolites After Oral Indole-3-Carbinol Treatment in Humans
Michnovicz, J. J., Adlercreutz, H., & Bradlow, H. L. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.10.718 · Cited by 146
Takada, Y., Andreeff, M., & Aggarwal, B. B. (2005) · Blood · doi:10.1182/blood-2004-12-4589 · Cited by 143
Self-citationCover, C. M., Hsieh, S.-J. J., Cram, E. J., Hong, C., Riby, J. E., Bjeldanes, L. F., & Firestone, G. L. (1999) · PubMed · Cited by 143
Xu, M., Bailey, A. C., Hernaez, J. F., Taoka, C. R., Schut, H. A. J., & Dashwood, R. H. (1996) · Carcinogenesis · doi:10.1093/carcin/17.7.1429 · Cited by 139
Meng, Q., Qi, M., Chen, D., Yuan, R., Goldberg, I. D., Rosen, E. M., Auborn, K. J., & Fan, S. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000088 · Cited by 136
Jeong, W., Keum, Y.-S., Chen, C., Jain, M. R., Shen, G., Kim, J. H., Li, W., & Kong, A. T. (2005) · BMB Reports · doi:10.5483/bmbrep.2005.38.2.167 · Cited by 133
Long-term responses of women to indole-3-carbinol or a high fiber diet.
Bradlow, H. L., Michnovicz, J. J., Halper, M., Miller, D. G., Wong, G. Y., & Osborne, M. P. (1994) · PubMed · Cited by 129
Rahman, K. W., & Sarkar, F. H. (2005) · PubMed · Cited by 127
Liu, H., Wormke, M., & Safe, S. H. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.23.1758 · Cited by 127
Zheng, Q., Hirose, Y., Yoshimi, N., Murakami, A., Koshimįzu, K., Ohigashi, H., Sakata, K., Matsumoto, Y., Sayama, Y., & Mori, H. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-002-0373-y · Cited by 127
Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner
Lee, S., Kim, J., Yamaguchi, K., Eling, T. E., & Baek, S. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.138 · Cited by 120
Indole-3-Carbinol Is a Negative Regulator of Estrogen Receptor-α Signaling in Human Tumor Cells
Meng, Q., Yuan, F., Goldberg, I., Rosen, E., Auborn, K., & Fan, S. (2000) · Journal of Nutrition · doi:10.1093/jn/130.12.2927 · Cited by 119
Guo, D., Schut, H. A. J., Davis, C. D., Snyderwine, E. G., Bailey, G. S., & Dashwood, R. H. (1995) · Carcinogenesis · doi:10.1093/carcin/16.12.2931 · Cited by 116
Cram, E. J., Liu, B. D., Bjeldanes, L. F., & Firestone, G. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010539200 · Cited by 114
Chang, Y., Riby, J. E., Chang, G. H.-F., Peng, B., Firestone, G. L., & Bjeldanes, L. F. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00165-3 · Cited by 108
Li, Y., Li, X., & Sarkar, F. H. (2003) · Journal of Nutrition · doi:10.1093/jn/133.4.1011 · Cited by 107
Howells, L. M., Gallacher, B., Houghton, C. E., Manson, M. M., & Hudson, E. A. (2002) · PubMed · Cited by 99
Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells
Meng, Q., Goldberg, I. D., Rosen, E. M., & Fan, S. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006495824158 · Cited by 89
Rahman, K., Aranha, O., Glazyrin, A. L., Chinni, S. R., & Sarkar, F. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203959 · Cited by 88
Stresser, D. M., Williams, D. E., Griffin, D. A., & Bailey, G. S. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06735-2 · Cited by 87
Katdare, M., Osborne, M. P., & TELANG, N. T. (1998) · Oncology Reports · doi:10.3892/or.5.2.311 · Cited by 86
Riby, J. E., Chang, G. H. F., Firestone, G. L., & Bjeldanes, L. F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00307-5 · Cited by 84
Fate of Indole-3-carbinol in Cultured Human Breast Tumor Cells
Staub, R. E., Feng, C., Onisko, B., et al. (2002) · Chemical Research in Toxicology · doi:10.1021/tx010056m · Cited by 77
Indole-3-carbinol as a scavenger of free radicals
Arnao, M. B., Sánchez‐Bravo, J., & Acosta, M. (1996) · IUBMB Life · doi:10.1080/15216549600201302 · Cited by 76
Stresser, D. M., Williams, D. E., McLellan, L. I., Harris, T. M., & Bailey, G. S. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08388-6 · Cited by 74
Zhang, J., Hsu, J. C., Kinseth, M. A., Bjeldanes, L. F., & Firestone, G. L. (2003) · Cancer · doi:10.1002/cncr.11844 · Cited by 73
McDougal, A. J., Gupta, M. S., Morrow, D., Ramamoorthy, K., Lee, J., & Safe, S. H. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010608000074 · Cited by 72
Riby, J. E., Feng, C., Chang, Y., Schaldach, C., Firestone, G. L., & Bjeldanes, L. F. (2000) · Biochemistry · doi:10.1021/bi9919706 · Cited by 68
Intervention in free radical mediated hepatotoxicity and lipid peroxidation by indole-3-carbinol
Shertzer, H. G., Berger, M. L., & Tabor, M. W. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90737-x · Cited by 68
Sanderson, J. T. (2001) · Toxicological Sciences · doi:10.1093/toxsci/61.1.40 · Cited by 65
Diindolylmethane Alters Gene Expression in Human Keratinocytes In Vitro
Carter, T. H., Liu, K., Ralph, W., Chen, D., Qi, M., Fan, S., Fang, Y., Rosen, E. M., & Auborn, K. J. (2002) · Journal of Nutrition · doi:10.1093/jn/132.11.3314 · Cited by 65
Blum, C. A., Xu, M., Orner, G. A., Fong, A. T., Bailey, G. S., Stoner, G. D., Horio, D. T., & Dashwood, R. H. (2001) · Carcinogenesis · doi:10.1093/carcin/22.2.315 · Cited by 64
Sun, S., Han, J., Ralph, W. M., Chandrasekaran, A., Liu, K., Auborn, K. J., & Carter, T. H. (2004) · Cell Stress and Chaperones · doi:10.1379/csc-2r.1 · Cited by 62
Brandi, G., Paiardini, M., Cervasi, B., Fiorucci, C., Fïlippone, P., Marco, C. D., Zaffaroni, N., & Magnani, M. (2003) · PubMed · Cited by 60
Leong, H., Firestone, G. L., & Bjeldanes, L. F. (2001) · Carcinogenesis · doi:10.1093/carcin/22.11.1809 · Cited by 60
Lieshout, E. M. M. V., Posner, G. H., Woodard, B. T., et al. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00112-8 · Cited by 59
Williams, D. E., Katchamart, S., Larsen-Su, S. A., Stresser, D. M., Dehal, S. S., & Kupfer, D. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0667-6_95 · Cited by 50
Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer.
Ashok, B. T., Chen, Y. G., Liu, X., Garikapaty, V. P. S., Seplowitz, R., Tschorn, J., Roy, K., Mittelman, A., & Tiwari, R. K. (2002) · PubMed · Cited by 47
Jeon, K., Rih, J.-K., Kim, H. J., Lee, Y. J., Cho, C., Goldberg, I. D., Rosen, E. M., & Bae, I. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00473-3 · Cited by 46
Stephensen, P. U., Bonnesen, C., Schaldach, C., Andersen, O., Bjeldanes, L. F., & Vang, O. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3601_15 · Cited by 45
Lian, J. P., Word, B. R., Taylor, S., Hammons, G., & Lyn‐Cook, B. D. (2004) · PubMed · Cited by 45
Increased estrogen 2-hydroxylation in obese women using oral indole-3-carbinol
Michnovicz, J. J. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800573 · Cited by 41
Influence of indole-3-carbinol on the hepatic microsomal formation of catechol estrogens
Jellinck, P. H., Michnovicz, J. J., & Bradlow, H. L. (1991) · Steroids · doi:10.1016/0039-128x(91)90034-s · Cited by 40
Abrogation of Estrogen-Mediated Cellular and Biochemical Effects by Indole-3-Carbinol
Ashok, B. T., Chen, Y., Liu, X., Bradlow, H. L., Mittelman, A., & Tiwari, R. K. (2001) · Nutrition and Cancer · doi:10.1080/01635581.2001.9680630 · Cited by 40
Dietary and Pharmacological Control of Estradiol Metabolism in Humans a
Michnovicz, J. J., & Bradlow, H. L. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb34303.x · Cited by 39
Auborn, K. J., Qi, M., Yan, X., Teichberg, S., Chen, D.-Z., Madaio, M. P., & Chiorazzi, N. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3610 · Cited by 37
Chatterji, U. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh121 · Cited by 35
Indole‐3‐carbinol activates the cyclin‐dependent kinase inhibitor p15INK4b gene
Matsuzaki, Y., Koyama, M., Hitomi, T., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.002 · Cited by 28
Endocrine Disruption by Indole-3-carbinol and Tamoxifen: Blockage of Ovulation
Gao, X., Petroff, B. K., Oluola, O., Georg, G. I., Terranova, P. F., & Rozman, K. K. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9478 · Cited by 20
van der Logt, E. M. J., Roelofs, H. M. J., Lieshout, E. M. M. V., Nagengast, F. M., & Peters, W. H. M. (2004) · PubMed · Cited by 19
Ritter, C. L., Prigge, W. F., Reichert, M. A., & Malejka‐Giganti, D. (2001) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-79-6-519 · Cited by 13
Inhibition of MUC1 expression by indole‐3‐carbinol
Lee, I. J., Han, F., Baek, J. H., Hisatsune, A., & Kim, K. C. (2004) · International Journal of Cancer · doi:10.1002/ijc.20031 · Cited by 13
Cited by
Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis
HIGDON, J., DELAGE, B., WILLIAMS, D., & DASHWOOD, R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.01.009 · Cited by 1,039
The Search for Endogenous Activators of the Aryl Hydrocarbon Receptor
Nguyen, L. P., & Bradfield, C. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx7001965 · Cited by 709
Anticancer Efficacy of Polyphenols and Their Combinations
Niedzwiecki, A., Roomi, M., Kalinovsky, T., & Rath, M. (2016) · Nutrients · doi:10.3390/nu8090552 · Cited by 538
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
NITULESCU, G. M., MARGINA, D., JUZENAS, P., PENG, Q., OLARU, O. T., SALOUSTROS, E., FENGA, C., SPANDIDOS, D. A., LIBRA, M., & TSATSAKIS, A. M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2015.3306 · Cited by 364
Hormetic Dietary Phytochemicals
Son, T. G., Camandola, S., & Mattson, M. P. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8037-y · Cited by 356
Metadata
- Authors
- Aggarwal, B. B., & Ichikawa, H.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2005-07-06
- Volume
- 4
- Issue
- 9
- Pages
- 1201-1215
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2043620261
- Cited by
- 434
- References
- 71
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.